Antiarrhythmic drug effects on QT interval dispersion in patients undergoing electropharmacologic testing for ventricular tachycardia and fibrillation. [electronic resource]
- The American journal of cardiology Mar 1998
- 588-93 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
0002-9149
10.1016/s0002-9149(97)00967-3 doi
Aged Anti-Arrhythmia Agents--therapeutic use Female Heart Conduction System--drug effects Humans Male Middle Aged Myocardial Infarction--complications Predictive Value of Tests Tachycardia, Ventricular--complications Treatment Outcome Vascular Patency Ventricular Fibrillation--complications